Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure

Background: Carbapenems are the treatment of choice for multidrug-resistant (MDR) and extensively drug-resistant (XDR)  Acinetobacter baumannii infections, but the emergence of carbapenem-resistant  A. baumannii (CRAB) has rendered it ineffective in the vast majority of cases. Combination therapy ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivani, Erizka, Endraswari, Pepy Dwi, Widodo, Agung Dwi Wahyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723411/
https://www.ncbi.nlm.nih.gov/pubmed/36531260
http://dx.doi.org/10.12688/f1000research.122221.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723411/
https://www.ncbi.nlm.nih.gov/pubmed/36531260
http://dx.doi.org/10.12688/f1000research.122221.2

Ejemplares similares